HIV postexposure prophylaxis: Who should get it?
J Fam Pract. 2006 Jul;55(7):600-4.
HIV postexposure prophylaxis: Who should get it?
‘Campos-Outcalt D.
Department of Family and Community Medicine, University of Arizona College of Medicine, 4001 North Third Street 415, Phoenix, AZ 85012, USA. dougco@u.arizona.edu’
In most cases, HIV postexposure prophylaxis (PEP) is given only to healthcare workers if the settings make exposure to HIV-infected persons likely. Otherwise, it is usually deemed unnecessary. However, a decision for or against PEP is complicated. Occupational and nonoccupational exposure to HIV can produce fear, anxiety, and stress. Information on the exposure risk is frequently incomplete, the risk of infection is usually low, the degree of protection offered by PEP is not fully defined, and the potential for side effects from the medications is significant. This article distills the Centers for Disease Control and Prevention’s most recent guidance on HIV PEP.
MeSH Terms: Algorithms – Anti-HIV Agents/therapeutic use* – Disease Transmission/prevention & control – Disease Transmission, Patient-to-Professional/prevention & control* – HIV Infections/prevention & control – HIV Infections/transmission* – Health Perso
Chercher cette référence sur : Google Scholar, Worldcat
